129 related articles for article (PubMed ID: 36380651)
1. COVID-19 Pandemic Lockdowns' Impact on Visual Acuity of Diabetic Macular Edema: A Large Cohort.
Gomel N; Shor R; Lippin N; Segal O; Greenbaum E; Schwartz S; Trivizki O; Loewenstein A; Rabina G
Ophthalmologica; 2023; 246(1):1-8. PubMed ID: 36380651
[TBL] [Abstract][Full Text] [Related]
2. [Impact of the SARS-CoV-2 pandemic on diabetic macular edema and prognostic factors].
Khodriss C; El Harch I; Bennis A; Chraibi F; El Fakir S; Abdellaoui M; Tachfouti N; Benatiya Andaloussi I
J Fr Ophtalmol; 2021 Nov; 44(9):1313-1318. PubMed ID: 34538511
[TBL] [Abstract][Full Text] [Related]
3. Delayed anti-VEGF injections during the COVID-19 pandemic and changes in visual acuity in patients with three common retinal diseases: A systematic review and meta-analysis.
Im JHB; Jin YP; Chow R; Dharia RS; Yan P
Surv Ophthalmol; 2022; 67(6):1593-1602. PubMed ID: 35970234
[TBL] [Abstract][Full Text] [Related]
4. Real-World Outcomes after 36-Month Treatment with Ranibizumab 0.5 mg in Patients with Visual Impairment due to Diabetic Macular Edema (BOREAL-DME).
Massin P; Creuzot-Garcher C; Kodjikian L; Girmens JF; Delcourt C; Fajnkuchen F; Glacet-Bernard A; Guillausseau PJ; Guthux F; Blin P; Grelaud A
Ophthalmic Res; 2021; 64(4):577-586. PubMed ID: 32932257
[TBL] [Abstract][Full Text] [Related]
5. Anatomical and functional responses in eyes with diabetic macular edema treated with "1 + PRN" ranibizumab: one-year outcomes in population of mainland China.
Lai K; Huang C; Li L; Gong Y; Xu F; Zhong X; Lu L; Jin C
BMC Ophthalmol; 2020 Jun; 20(1):229. PubMed ID: 32539744
[TBL] [Abstract][Full Text] [Related]
6. One-Year Results of Using a Treat-and-Extend Regimen without a Loading Phase with Anti-VEGF Agents in Patients with Treatment-Naive Diabetic Macular Edema.
Schwarzer P; Ebneter A; Munk M; Wolf S; Zinkernagel MS
Ophthalmologica; 2019; 241(4):220-225. PubMed ID: 30654365
[TBL] [Abstract][Full Text] [Related]
7. Diabetic macular oedema treated with intravitreal anti-vascular endothelial growth factor - 2-4 years follow-up of visual acuity and retinal thickness in 566 patients following Danish national guidelines.
Hodzic-Hadzibegovic D; Sander BA; Monberg TJ; Larsen M; Lund-Andersen H
Acta Ophthalmol; 2018 May; 96(3):267-278. PubMed ID: 29240306
[TBL] [Abstract][Full Text] [Related]
8. IMPACT OF COVID-19 PANDEMIC LOCKDOWNS ON VISUAL ACUITY OF PATIENTS WITH NEOVASCULAR AMD: A Large Cohort.
Shor R; Segal O; Mimouni M; Greenbaum E; Zur D; Trivizki O; Schwartz S; Loewenstein A; Goldstein M; Rabina G
Retina; 2022 Aug; 42(8):1529-1535. PubMed ID: 35502974
[TBL] [Abstract][Full Text] [Related]
9. A multicenter, 12-month randomized study comparing dexamethasone intravitreal implant with ranibizumab in patients with diabetic macular edema.
Callanan DG; Loewenstein A; Patel SS; Massin P; Corcóstegui B; Li XY; Jiao J; Hashad Y; Whitcup SM
Graefes Arch Clin Exp Ophthalmol; 2017 Mar; 255(3):463-473. PubMed ID: 27632215
[TBL] [Abstract][Full Text] [Related]
10. Dril Influences Short-term Visual Outcome after Intravitreal Corticosteroid Injection for Refractory Diabetic Macular Edema.
Luís ME; Sampaio F; Costa J; Cabral D; Teixeira C; Ferreira JT
Curr Eye Res; 2021 Sep; 46(9):1378-1386. PubMed ID: 33463388
[No Abstract] [Full Text] [Related]
11. Impact on visual acuity and psychological outcomes of ranibizumab and subsequent treatment for diabetic macular oedema in Japan (MERCURY).
Sakamoto T; Shimura M; Kitano S; Ohji M; Ogura Y; Yamashita H; Suzaki M; Mori K; Ohashi Y; Yap PS; Kaneko T; Ishibashi T;
Graefes Arch Clin Exp Ophthalmol; 2022 Feb; 260(2):477-487. PubMed ID: 34477927
[TBL] [Abstract][Full Text] [Related]
12. Comparing the Efficacy of Bevacizumab and Ranibizumab in Patients with Diabetic Macular Edema (BRDME): The BRDME Study, a Randomized Trial.
Vader MJC; Schauwvlieghe AME; Verbraak FD; Dijkman G; Hooymans JMM; Los LI; Zwinderman AH; Peto T; Hoyng CB; van Leeuwen R; Vingerling JR; Moll AC; van Lith-Verhoeven JJC; Dijkgraaf MGW; Schlingemann RO;
Ophthalmol Retina; 2020 Aug; 4(8):777-788. PubMed ID: 32362552
[TBL] [Abstract][Full Text] [Related]
13. The incidence and risk factors for the development of vitreomacular interface abnormality in diabetic macular edema treated with intravitreal injection of anti-VEGF.
Chang CK; Cheng CK; Peng CH
Eye (Lond); 2017 May; 31(5):762-770. PubMed ID: 28106889
[TBL] [Abstract][Full Text] [Related]
14. Postponed care due to COVID-19 lockdown impact on visual acuity of retinal vein occlusion patients: a large cohort.
Cohen R; Shor R; Segal O; Greenbaum E; Ayalon A; Trivizki O; Schwartz S; Loewenstein A; Rabina G
Graefes Arch Clin Exp Ophthalmol; 2023 Jan; 261(1):43-48. PubMed ID: 35819483
[TBL] [Abstract][Full Text] [Related]
15. Treatment patterns and visual acuity change of AMD patients, before, during and after the COVID-19 pandemic lockdowns: A large cohort.
Barequet D; Shor R; Segal O; Greenbaum E; Trivizki O; Loewenstein A; Rabina G
Acta Ophthalmol; 2024 May; 102(3):e322-e327. PubMed ID: 37698269
[TBL] [Abstract][Full Text] [Related]
16. Clinical Characteristics and Long-term Outcomes in Diabetic Macular Edema Patients: With or without Additional Injection Following Ranibizumab Loading.
Yoon K; Kim ES; Yu SY; Kim K
Korean J Ophthalmol; 2022 Oct; 36(5):398-406. PubMed ID: 35989066
[TBL] [Abstract][Full Text] [Related]
17. The impact of delayed anti-vascular endothelial growth factor treatment for retinal diseases during the COVID-19 lockdown.
Bulut MN; Sönmez HS; Gökçe G; Ağaçkesen A; Bulut K; Hacısalihoğlu A; Arsan A; Şimşek Ş
Photodiagnosis Photodyn Ther; 2021 Sep; 35():102449. PubMed ID: 34314862
[TBL] [Abstract][Full Text] [Related]
18. Impact of Cataract Surgery during Treatment with Ranibizumab in Patients with Diabetic Macular Edema.
Moshfeghi AA; Shapiro H; Lemmon LA; Gune S
Ophthalmol Retina; 2018 Feb; 2(2):86-90. PubMed ID: 31047350
[TBL] [Abstract][Full Text] [Related]
19. Effect of Adding Dexamethasone to Continued Ranibizumab Treatment in Patients With Persistent Diabetic Macular Edema: A DRCR Network Phase 2 Randomized Clinical Trial.
Maturi RK; Glassman AR; Liu D; Beck RW; Bhavsar AR; Bressler NM; Jampol LM; Melia M; Punjabi OS; Salehi-Had H; Sun JK;
JAMA Ophthalmol; 2018 Jan; 136(1):29-38. PubMed ID: 29127949
[TBL] [Abstract][Full Text] [Related]
20. Impact of Intravitreal Ranibizumab Therapy on Vision Outcomes in Diabetic Macular Edema Patients: A Meta-Analysis.
Falcão M
Ophthalmologica; 2020; 243(4):243-254. PubMed ID: 31775144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
